Brouwinkind Pharmalab Private Limited

Brouwinkind Pharmalab Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
CIN U33110DL2008PTC183320 Incorporated 16 September 2008 ROC Delhi HQ Delhi, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹12,235
▲ 20% YoY
Net loss · FY 2024
₹47,188
Net margin -385.7%
EBITDA · FY 2024
-₹18,038
EBITDA margin -147.4%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹3.5 Cr
Secured borrowings
Company age
18 yrs
Est. 2008
Directors on board
2
As per MCA filings

About Brouwinkind Pharmalab Private Limited

Data last updated:

Brouwinkind Pharmalab Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 September 2008 and has been in existence for over 18 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33110DL2008PTC183320. Its GSTIN is 07AADCB5703B1ZA (Delhi).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It was formerly known as Burroughs Wellcome Pharmalab Private Limited and Burroughs Wellcome Pharmalab Limited. It is led by directors Parkash Thirani and August Kumar Thirani.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 12 109/2 Cc Colony Buddha Appartment, Delhi, India – 110009.

As per the financials filed for FY 2024, the company reported a revenue of ₹12,235, a growth of 20% compared to the previous year. For the same year it recorded a net loss of ₹47,188 (net margin -385.7%) and EBITDA of -₹18,038 (EBITDA margin -147.4%). Revenue has declined at a compounded annual rate (CAGR) of 79% over five years.

As per MCA filings, the company has open charges of ₹3.5 Cr on record. Court records list 7 cases involving the company, including 6 filed by the company and 1 filed against it.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U33110DL2008PTC183320
Registration Number 183320
Incorporation Date 16 September 2008
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Name history

Brouwinkind Pharmalab has undergone 2 name changes throughout its history. The company was previously known as Burroughs Wellcome Pharmalab Private Limited, and Burroughs Wellcome Pharmalab Limited. The current legal name is Brouwinkind Pharmalab Private Limited.

Company NameStatus
Brouwinkind Pharmalab Private LimitedCurrent
Burroughs Wellcome Pharmalab Private LimitedPrevious
Burroughs Wellcome Pharmalab LimitedPrevious

CIN history

Brouwinkind Pharmalab has one previous CIN (Corporate Identification Number): U33110DL2008PLC183320. The current CIN is U33110DL2008PTC183320, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U33110DL2008PTC183320Current
U33110DL2008PLC183320Previous

Contact details

Brouwinkind Pharmalab Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Flat No. 12 109/2 Cc Colony Buddha Appartment, Delhi, India – 110009
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Brouwinkind Pharmalab Private Limited, buy the company report.

Comprehensive company report
Brouwinkind Pharmalab Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Brouwinkind Pharmalab Private Limited

FY 2025 filings available

Brouwinkind Pharmalab Private Limited reported revenue of ₹12,235 (up 20% YoY) for FY 2024.

Revenue · FY 2024
₹12,235 ▲ 20%
Net loss · FY 2024
₹47,188 margin -385.7%
EBITDA · FY 2024
-₹18,038 margin -147.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 20%
5 years · compounded
▼ 79%
EBITDA CAGR growth
1 year
▲ 47%
3 years · compounded
▲ 78%
5 years · compounded
▼ 16%

Revenue rose 20% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 79%. EBITDA rose 47% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹18,038
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹47,188
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin-147.4%
Net Profit Margin-385.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Brouwinkind Pharmalab Private Limited, buy the company report.

Board of directors of Brouwinkind Pharmalab Private Limited

Brouwinkind Pharmalab has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Parkash ThiraniDirector09 Jul 200917 Years 3 MonthsCurrent
August Kumar ThiraniDirector09 Jul 200917 Years 3 MonthsCurrent

Peer comparison

Brouwinkind Pharmalab Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Galaxystar Pharma Private Limited₹13,151 (FY 2022)-93.0%Mumbai, Maharashtra, India
Healwell Pharmaceuticals Private Limited₹13,094 (FY 2024)4.0%Delhi, India
Drish Lifesciences Limited₹13,039 (FY 2024)7.0%Jalandhar, Punjab, India
Nurturaa Health Tech Private Limited₹13,000 (FY 2025)Hyderabad, Telangana, India
Mediways Chemist Private Limited₹12,483 (FY 2025)438.0%Ghaziabad, Uttar Pradesh, India
Brouwinkind Pharmalab Private Limitedthis company₹12,235 (FY 2024)-₹47,188-385.7%20.0%Delhi, India
Aarti Pharmaceuticals Private Limited₹12,211 (FY 2025)New Delhi, Delhi, India
Remedy Drugs Pvt Ltd₹12,055 (FY 2025)Indore, Madhya Pradesh, India
Vios Aiming Progress Private Limited₹12,000 (FY 2018)Bhopal, Madhya Pradesh, India
Gracious Healthcare Private Limited₹12,000 (FY 2024)18.0%Delhi, India
Ishir Pharmaceuticals Private Limited₹12,000 (FY 2023)76.0%New Delhi, Delhi, India

To see the full peer comparison of Brouwinkind Pharmalab Private Limited, buy the company report.

Auditor

Brouwinkind Pharmalab Private Limited is audited by R BHARGAVA & ASSOCIATES for the financial year 2019.

Auditor firmFinancial yearFirm registration number
R BHARGAVA & ASSOCIATESFY 2019012788N

Shareholding

The shareholding of Brouwinkind Pharmalab Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Brouwinkind Pharmalab Private Limited, buy the company report.

Charges & borrowings

Open charges
₹3.5 Cr
Satisfied charges
None
Breakdown by lending institutions
Uco Bank₹3.50 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
26 Aug 200910173537Uco Bank₹3.5 CrOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Brouwinkind Pharmalab Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Brouwinkind Pharmalab has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07AADCB5703B1ZADelhiActive01 Jul 2017

To see the full GST registrations and return filing status of Brouwinkind Pharmalab Private Limited, buy the company report.

Recent activity

Brouwinkind Pharmalab Private Limited has 5 board changes on record since 2009: 2 appointments and 3 cessations. The latest: Mahesh Kumar Bhartia ceased to be Director on 01 Nov 2011.

AGM
Brouwinkind Pharmalab Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Brouwinkind Pharmalab Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Ceased
Mahesh Kumar Bhartia ceased to be Director.
Ceased
Suresh Kumar Bharatia ceased to be Director.
Ceased
Vishwambhar Dayal Bhartia ceased to be Director.
Charges
A charge with Uco Bank amounted to Rs. 350.00 Lakh with Charge ID 10173537 was registered on 26 Aug 2009.
Appointed
August Kumar Thirani was appointed as Director.
Appointed
Parkash Thirani was appointed as Director.
Incorporation
16 Sep 2008
Brouwinkind Pharmalab Private Limited was registered on 16 Sep 2008 with Roc Delhi Ii & aged 18 years 1 month as per MCA records.

Frequently asked questions

Brouwinkind Pharmalab is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 September 2008 (18+ years old) and is registered under CIN U33110DL2008PTC183320.

Brouwinkind Pharmalab has 2 current directors:

The latest financial statements of Brouwinkind Pharmalab on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Brouwinkind Pharmalab is 07AADCB5703B1ZA, registered in Delhi.

The CIN (Corporate Identification Number) of Brouwinkind Pharmalab is U33110DL2008PTC183320. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Brouwinkind Pharmalab has 7 court cases on record: 6 filed by the company and 1 filed against it. Most are in the district courts.

Brouwinkind Pharmalab was incorporated on 16 September 2008, making it 18+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Brouwinkind Pharmalab by revenue are Galaxystar Pharma Private Limited, Healwell Pharmaceuticals Private Limited, Drish Lifesciences Limited, Nurturaa Health Tech Private Limited, Mediways Chemist Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).

Mahesh Kumar Bhartia ceased to be Director on 01 Nov 2011. Suresh Kumar Bharatia ceased to be Director on 01 Nov 2011. Vishwambhar Dayal Bhartia ceased to be Director on 01 Nov 2011. Brouwinkind Pharmalab has 5 board changes on record in total.

The registered office of Brouwinkind Pharmalab is at Flat No. 12 1092 Cc Colony Buddha Appartment, Delhi, India – 110009.

Brouwinkind Pharmalab operates in the pharma industry, in the pharmaceutical retailers and distributors segment.